IXICO plc (LON:IXI – Get Free Report)’s stock price was up 16.9% during trading on Tuesday. The stock traded as high as GBX 12.50 and last traded at GBX 11.98. Approximately 449,418 shares were traded during trading, an increase of 314% from the average session volume of 108,557 shares. The stock had previously closed at GBX 10.25.
IXICO Price Performance
The company has a debt-to-equity ratio of 5.22, a quick ratio of 4.90 and a current ratio of 2.83. The stock has a market capitalization of £26.23 million, a price-to-earnings ratio of -6.14, a price-to-earnings-growth ratio of -0.38 and a beta of 0.11. The business’s 50 day simple moving average is GBX 7.89 and its 200-day simple moving average is GBX 8.28.
IXICO Company Profile
IXICO is a global leader in neuroscience imaging and biomarker analytics, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring.
By unlocking valuable insights into drug safety and efficacy, IXICO has built a global reputation and 20-year track record as an end-to-end Imaging Contract Research Organisation (iCRO) managing and analysing neurological clinical trials.
Further Reading
- Five stocks we like better than IXICO
- Charging Ahead: Solid Power’s Pilot Line Leaves the Lab
- Off-Price, High-Yield: Why Ross Stores Is Defying the Retail Slump
- Whirlpool’s Stock Collapse Raises a Bigger Question About Its Recovery Potential
- Analysts Turn Bullish on Meta Platforms Despite Post-Earnings Fall
Receive News & Ratings for IXICO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IXICO and related companies with MarketBeat.com's FREE daily email newsletter.
